On Wednesday 21 February, representatives from patients, academics, industries, professionals & regulators (i.a. FEDCAR) will gather and address various aspects of health issues that are at stake with the Brexit.
At a critical time when both the UK Government and the EU are preparing for phase II of the Article 50 negotiations, we would like to invite you to this event which will focus on what needs to urgently be prioritised in the negotiations in order to preserve patient safety and public health. To register your attendance, click here.
This event follows a letter addressed in December to EU Public Health Ministers outlining those issues.
WHERE IN BRUSSELS?
24 rue de l’industrie.
In the UEMS headquarters.
WHEN IN THE AFTERNOON?
From 1.30 to 4.30.
Peter O’Donnel, EU-accredited Brussels-based journalist.
14:00- 14:10: Welcome and introduction by Nicola Bedlington, European Patients Forum – presenting the joint statement and the key priorities for patients in the Brexit negotiations
14:10 – 14:35: Public Health
Fiona Godfrey, representing the European Public Health Alliance (EPHA)
14:35 – 15:05: Access to medicines and medical technologies
Mark Lloyd Davies, Senior Director, Government Affairs & Policy at Johnson & Johnson
Cathalijne van Doorne, Vice President, European Federation of Neurological Associations (EFNA)
15:05 – 15:35: Research and innovation
Catherine Guinard, Cancer Research UK
15:35 – 16:05: Mobility for patients and health care professionals
Pascal Garel, Executive Director, HOPE
Matt Bolz-Johnson, Healthcare and Research Director, EURORDIS
16:05 – 16:15: Closing statement from Rory Palmer MEP
16:15 – 16:30: Close
FYI – Click here for a NHS perspective (on patient access to medicines and medical technologies).